Jesús
Corral Jaime
Investigador hasta 2022
Christie Hospital NHS Foundation Trust
Mánchester, Reino UnidoPublicaciones en colaboración con investigadores/as de Christie Hospital NHS Foundation Trust (4)
2017
-
Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease
Clinical Lung Cancer, Vol. 18, Núm. 1, pp. 68-76.e2
-
Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey
Annals of Oncology, Vol. 28, Núm. 7, pp. 1590-1596